Mettler-Toledo International (MTD), a leading global provider in medical and healthcare sector, has faced a wide scope of reactions including both upgrades and downgrades from investment entities. Wall Street Zen and Barclays granted MTD with a positive boost, with a 'buy' and 'overweight' rating respectively. Conversely, the stock has also been on an 8-day losing streak, with evident slide of 8.3% in its value. Recent reports claim MTD to be underperforming in healthcare sector in comparison to its valuation. The stakes in MTD by Virginia Retirement Systems and Canoe Financial lessened, meanwhile not lacking interest from other investment firms such as Beacon Investment Advisory Services and Voya Investment Management. With its Q3 earnings conference call, MTD showed promising growth with support from analysts. Despite an overall decrease in position from various entities, MTD managed to raise its price target to $1450 by Wells Fargo & Company. Being dubbed as a 'Strong Growth Stock', the company displayed robust performance in Q3 2025 with a steady earnings beat. Yet, insider transactions like those from Vadala Shawn and CEO Kaltenbach, hint towards a potential sell-off. Nevertheless, investment in MTD five years ago would have given you a 47% gain.
Mettler-Toledo International MTD News Analytics from Thu, 09 Aug 2007 07:00:00 GMT to Sat, 03 Jan 2026 06:35:17 GMT -
Rating 3
- Innovation 1
- Information 7
- Rumor 2
